Scout Micro Competitors

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning. We are a company of diverse employees with a wide range of backgrounds and experiences. Our world class team is passionate about solving challenging problems and making a huge impact. Our office is located in the heart of Fenway. PathAI was recently voted one of BBJ's Best Places to Work!

From discovery to diagnosis, the HALO® suite supports the full digital pathology journey. Indica Labs delivers AI-powered solutions spanning life science research, translational science, pharmaceutical development, companion diagnostics, and clinical deployment. Today, HALO has surpassed 3,000 deployments across 35 countries and six continents, supporting all 20 of the world’s top pharmaceutical companies and research cited in more than 2,600 peer-reviewed publications. That global research footprint is increasingly translating into clinical adoption, with HALO AP® clinical revenue growing 260% since 2023 and recurring clinical revenue increasing 200% year-over-year in 2025. From HALO®, HALO AI, and HALO Link to HALO AP® (CE-IVDR marked) and HALO AP Dx (FDA 510k cleared), one connected ecosystem helps bridge discovery, development, validation, and clinical implementation. One HALO ecosystem. From life science discovery to clinical deployment.